TLR9
TLR9 (toll-like receptor 9, CD289) is a nucleotide-sensing member of the Toll-like receptor family that detects unmethylated CpG dinucleotides. It helps drive innate and adaptive immune responses to microbial pathogens. Browse Assay Genie's current range of TLR9 research reagents below, or read on for the biology behind the target.
TLR9 is a key component of innate and adaptive immunity. Toll-like receptors control the host immune response against pathogens by recognising molecular patterns specific to microorganisms. TLR9 is a nucleotide-sensing TLR activated by unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides, and studies in mice and humans indicate that it mediates the cellular response to CpG motifs in bacterial DNA to mount an innate immune response.
Once activated, TLR9 signals via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. It also acts via ADCY7, leading to cyclic di-AMP (c-di-AMP) synthesis and activation of the NLRP3 inflammasome. Upon CpG stimulation, TLR9 induces B-cell proliferation, activation, survival and antibody production. It plays a role in defence against systemic mouse cytomegalovirus infection and controls the lymphocyte response to Helicobacter infection.
The TLR9 gene encodes a member of the Toll-like receptor family, which is highly conserved from Drosophila to humans. TLRs share structural and functional similarities and recognise pathogen-associated molecular patterns (PAMPs) expressed on infectious agents, mediating the production of cytokines needed for effective immunity. TLR9 is found in several intracellular compartments, including the endoplasmic reticulum membrane, early endosome membrane, lysosome, phagosome and Golgi apparatus membrane. HGNC places it in the CD molecule and Toll-like receptor gene groups, and the mouse ortholog is Tlr9.
TLR9 is a nucleotide-sensing receptor that helps control the host response to pathogens through recognition of microbial molecular patterns.
TLR9 is activated by unmethylated CpG dinucleotides and mediates the cellular response to CpG motifs in bacterial DNA.
Upon CpG stimulation, TLR9 induces B-cell proliferation, activation, survival and antibody production.
TLR9 signals through MYD88 and TRAF6 to NF-kappa-B, and via ADCY7 to the NLRP3 inflammasome.
TLR9 is a nucleotide-sensing Toll-like receptor activated by unmethylated CpG dinucleotides. It signals via MYD88 and TRAF6 to activate NF-kappa-B, driving cytokine secretion and inflammation, and via ADCY7 to c-di-AMP synthesis and NLRP3 inflammasome activation. It also promotes B-cell proliferation, survival and antibody production.
TLR9 stands for toll-like receptor 9, and its alias is CD289. The HGNC gene name is toll like receptor 9. It belongs to the Toll-like receptor family and is grouped with CD molecules. The mouse ortholog is written Tlr9, so check the datasheet of any product for its validated reactivity.
Toll-like receptors are highly conserved from Drosophila to humans and share structural and functional similarities. Studies in mice and humans show that TLR9 mediates responses to unmethylated CpG DNA, and mouse Tlr9 contributes to defence against cytomegalovirus infection and the lymphocyte response to Helicobacter.
Other Toll-like receptors involved in pathogen recognition and innate immune signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NR96; product specifications from Assay Genie datasheets.